FDA Approval Insights: Durvalumab/Chemotherapy in dMMR Advanced Endometrial Cancer
Season 11, Episode 3, Aug 15, 06:20 PM
Dr Westin discusses the FDA approval of durvalumab plus chemotherapy for patients with dMMR advanced or recurrent endometrial cancer.